Merck COVID drug molnupiravir linked to virus mutation transmission
Published
Published
An antiviral drug that was granted an emergency use authorization by the U.S. Food and Drug Administration in December 2021 may be..
A worker handles a bottle of Merck & Co. and Ridgeback Biotherapeutics LPs Molnupiravir antiviral medication in a warehouse in..